Startseite/Aktien/TWST

TWST

USD

Twist Bioscience Corporation Common Stock

$30.060-0.970 (-3.126%)

Echtzeitkurs

Healthcare

Diagnostics & Research

Vereinigte Staaten

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen

Unternehmensfundamentaldaten

Handelsstatistiken

Marktkennzahlen

Eröffnung

$31.030

Hoch

$31.390

Tief

$29.715

Volumen

1.91M

Unternehmensfundamentaldaten

Marktkapitalisierung

1.8B

Branche

Diagnostics & Research

Land

United States

Handelsstatistiken

Durchschnittliches Volumen

1.74M

Börse

NMS

Währung

USD

52-Wochen-Spanne

Tief $24.07Aktuell $30.060Hoch $55.33

Ähnliche Nachrichten

4. Nov. 2025 · 13:04

Analyst Upgrades

Stephens & Co. Initiates Coverage On Twist Bioscience with Overweight Rating, Announces Price Target of $41

Stephens & Co. analyst Steven Etoch initiates coverage on Twist Bioscience with a Overweight rating and announces Price Target of $41.

Stephens & Co. Initiates Coverage On Twist Bioscience with Overweight Rating, Announces Price Target of $41

4. Nov. 2025 · 13:00

BusinessWire

Twist Bioscience to Present at 7th Annual Wolfe Research Healthcare Conference

Twist Bioscience Corporation (NASDAQ:TWST), a mid-cap growth and value biotech company, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience and Adam Laponis, CFO of Twist, will

Twist Bioscience to Present at 7th Annual Wolfe Research Healthcare Conference

3. Nov. 2025 · 13:00

BusinessWire

Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

As required by the rules of the Nasdaq Stock Market, Twist Bioscience Corporation (NASDAQ:TWST) ("Twist" or the "Company"), a mid-cap growth and value biotech company, today announced that it has granted a total of